4.7 Article

Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?

Related references

Note: Only part of the references are listed.
Review Cell & Tissue Engineering

Cross Talk between Mesenchymal Stem/Stromal Cells and Innate Immunocytes Concerning Lupus Disease

Mahmoud Mahmoudi et al.

Summary: Lupus is a systemic immune-mediated disorder with unknown cause and definitive treatment. Recently, mesenchymal stem/stromal cells (MSCs) have been widely used in research due to their anti-inflammatory and immunosuppressive properties. However, their potential in treating future immune-mediated disorders is still under investigation.

STEM CELL REVIEWS AND REPORTS (2022)

Review Rheumatology

A glimpse into the future of systemic lupus erythematosus

Martin Aringer et al.

Summary: This viewpoint article provides a forecast of clinically meaningful changes in the management of systemic lupus erythematosus (SLE) over the next 10 years. The article suggests significant advancements in diagnosis and treatment, including the use of musculoskeletal sonography for assessing lupus arthritis, polyomics studies to unravel the immune mechanisms of the disease, and the application of biomarkers for predicting therapeutic success.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2022)

Article Transplantation

Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results

Tineke Kraaij et al.

Summary: Combining RTX and BLM in B-cell targeted therapy showed promising clinical outcomes in refractory SLE patients, with improvements in clinical symptoms and reductions in autoantibody levels. The results of this study suggest that this treatment approach may serve as a novel strategy for managing SLE.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Review Immunology

Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus

Wen-Yan Tang et al.

Summary: Systemic lupus erythematosus (SLE) is a rare autoimmune disease that affects both sexes and races, with a higher incidence among the black population and women of reproductive age. Though incurable, personalized treatment can reduce symptoms. Mesenchymal stem cells have immunomodulatory functions and show promise in treating severe SLE.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2021)

Letter Rheumatology

Acute liver injury as initial manifestation of systemic lupus erythematosus-induced myocarditis

Antonia Neonaki et al.

RHEUMATOLOGY INTERNATIONAL (2021)

Article Cell & Tissue Engineering

Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1

Wang Chun et al.

Summary: The transplantation of UC-MSCs efficiently downregulated proteinuria and anti-dsDNA antibodies, corrected Treg/Th17/Th1 imbalances, and increased the frequency of B10 cells in SLE mice. The expression of TGF-beta 1 in MSCs was significantly increased after co-culture with B cells. Downregulation of TGF-beta 1 compromised the immunomodulation effects of MSCs on B10, Th17, and Treg cells, as well as the therapeutic effects of MSC transplantation.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell & Tissue Engineering

Adipose-derived mesenchymal stem cells from obese mice prevent body weight gain and hyperglycemia

Yicheng Qi et al.

Summary: The study evaluates the effects of adipose-derived MSCs from obese mice on body weight and glucose homeostasis, finding that these cells can reduce weight gain and improve obesity-related hyperglycemia in obese mice. This improvement is possibly attributed to increased lipolysis of inguinal fat and restoration of insulin receptor expression in muscle. Additionally, differential expression of CD90 and reduced levels of MCP-1 in O-ADSCs suggest that autologous ADSCs from obese individuals may be more effective for treating obesity and related hyperglycemia.

STEM CELL RESEARCH & THERAPY (2021)

Review Biochemistry & Molecular Biology

Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus

Haitao Yu et al.

Summary: Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease characterized by immune dysfunction. Clinical and immunological biomarkers are crucial for diagnosing, assessing, and controlling SLE, including novel biomarkers discovered through omics research.

BIOMOLECULES (2021)

Review Urology & Nephrology

An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis

Wenchao Li et al.

Summary: Bone marrow MSCs from SLE patients show impaired capabilities of migration, differentiation, and immune regulation, as well as a senescent phenotype. Allogeneic MSCs suppress autoimmunity and restore renal function in mouse models and LN patients by inducing regulatory immune cells and suppressing certain immune cell responses. Moreover, MSCs can migrate to the kidney, integrate into tubular cells, and differentiate into mesangial cells. There is still a need for further confirmation of the efficacy of MSCs in LN treatment, and advancements in stem cell science may lead to the use of more potent stimulated or primed pretreated MSCs for LN therapy.

KIDNEY DISEASES (2021)

Article Medicine, General & Internal

Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine

Sheng Wang et al.

Summary: This study observed differences in creatinine clearance in SLE patients with normal serum creatinine at different levels of urinary protein, showing a strong correlation between urinary protein levels and renal function. LN patients with positive urinary protein had higher levels of BUN and Cr. LN patients with urinary protein +/- or UPCR<0.15 g/g may exhibit renal hyperfunction.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)

Article Anatomy & Morphology

Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine

Qi-ling Yuan et al.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2020)

Article Urology & Nephrology

Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus

Jianyong Xu et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Veterinary Sciences

Defining body-weight reduction as a humane endpoint: a critical appraisal

Steven R. Talbot et al.

LABORATORY ANIMALS (2020)

Article Cell & Tissue Engineering

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis

Tianbiao Zhou et al.

STEM CELL RESEARCH & THERAPY (2020)

Review Cell Biology

Identifying the Therapeutic Significance of Mesenchymal Stem Cells

Vineet Kumar Mishra et al.

CELLS (2020)

Review Cell & Tissue Engineering

Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine

Alberto Gonzalez-Gonzalez et al.

WORLD JOURNAL OF STEM CELLS (2020)

Review Cardiac & Cardiovascular Systems

Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease

Abbas Shapouri Moghaddam et al.

ATHEROSCLEROSIS (2019)

Review Medicine, Research & Experimental

Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision

Ashif Iqubal et al.

LIFE SCIENCES (2019)

Review Medicine, Research & Experimental

Novel approaches using mesenchymal stem cells for curing peripheral nerve injuries

Forouzan Yousefi et al.

LIFE SCIENCES (2019)

Article Cell & Tissue Engineering

Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer

Patricia Luz-Crawford et al.

STEM CELL RESEARCH & THERAPY (2019)

Article Medicine, Legal

Variance of body and organ weights in 28-day studies in mice

Heike Antje Marxfeld et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)

Review Cell Biology

Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients

Rui-Juan Cheng et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Review Immunology

Curcumin: A natural modulator of immune cells in systemic lupus erythematosus

Amir Abbas Momtazi-Borojeni et al.

AUTOIMMUNITY REVIEWS (2018)

Article Medicine, Research & Experimental

Analysis of Th22, Th17 and CD4+ cells co-producing IL-17/IL-22 at different stages of human colon cancer

Hassan Doulabi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Cell Biology

Macrophage plasticity, polarization, and function in health and disease

Abbas Shapouri-Moghaddam et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Review Gastroenterology & Hepatology

Mesenchymal stromal cell therapy for liver diseases

Mohammed Alfaifi et al.

JOURNAL OF HEPATOLOGY (2018)

Review Urology & Nephrology

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Yufang Shi et al.

NATURE REVIEWS NEPHROLOGY (2018)

Review Cell & Tissue Engineering

Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus

Yantong Zhu et al.

STEM CELL RESEARCH & THERAPY (2018)

Review Rheumatology

Mouse models of lupus: what they tell us and what they don't

Mara Lennard Richard et al.

LUPUS SCIENCE & MEDICINE (2018)

Article Biochemistry & Molecular Biology

Protective Effects of Selenium on Cyclophosphamide-Induced Oxidative Stress and Kidney Injury

Sibel Gunes et al.

BIOLOGICAL TRACE ELEMENT RESEARCH (2018)

Article Health Care Sciences & Services

Toxic Effects of Different Doses of Cyclophosphamide on Liver and Kidney Tissue in Swiss Albino Mice: A Histopathological Study

Nandini Bhat et al.

ETHIOPIAN JOURNAL OF HEALTH SCIENCES (2018)

Article Medicine, Research & Experimental

Regulatory T Cells Compensation Failure Cause the Dysregulation of Immune Response in Pristane Induced Lupus Mice Model

Handono Kalim et al.

MALAYSIAN JOURNAL OF MEDICAL SCIENCES (2018)

Review Biochemistry & Molecular Biology

Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action

Tae-Hoon Shin et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Cell Biology

Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus

Seyed-Alireza Esmaeili et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2017)

Review Biochemistry & Molecular Biology

Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders

Patrizia Fasching et al.

MOLECULES (2017)

News Item Urology & Nephrology

Mesenchymal stromal cells in lupus nephritis

Willem E. Fibbe et al.

NATURE REVIEWS NEPHROLOGY (2017)

Review Biochemistry & Molecular Biology

Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective

Vaishali R. Moulton et al.

TRENDS IN MOLECULAR MEDICINE (2017)

Article Pharmacology & Pharmacy

Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c mice

Yihuang Lin et al.

ACTA PHARMACEUTICA SINICA B (2017)

Review Rheumatology

Pristane-induced lupus: considerations on this experimental model

Eduarda Correa Freitas et al.

CLINICAL RHEUMATOLOGY (2017)

Review Medicine, General & Internal

Mesenchymal stem cell (MSC) as a potential cell therapy for immune related disease

Bambang Hadi Kartiko et al.

BALI MEDICAL JOURNAL (2017)

Article Rheumatology

Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus

Kusworini Handono et al.

CLINICAL RHEUMATOLOGY (2016)

Review Cell & Tissue Engineering

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells

Mehdi Najar et al.

CYTOTHERAPY (2016)

Article Cell & Tissue Engineering

Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism

Ayal Rozenberg et al.

STEM CELLS TRANSLATIONAL MEDICINE (2016)

Review Immunology

The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases

Jacek Tabarkiewicz et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2015)

Article Medicine, Research & Experimental

Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion

Gang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Cell & Tissue Engineering

Transplantation of Adipose Tissue-Derived Mesenchymal Stem Cells Prevents the Development of Lupus Dermatitis

Eun Wha Choi et al.

STEM CELLS AND DEVELOPMENT (2015)

Article Biochemistry & Molecular Biology

Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds

Giovanni Marfia et al.

ORGANOGENESIS (2015)

Review Immunology

Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus

Timothy A. Gottschalk et al.

FRONTIERS IN IMMUNOLOGY (2015)

Review Oncology

Th17 Cells in autoimmune diseases

Lei Han et al.

FRONTIERS OF MEDICINE (2015)

Review Genetics & Heredity

Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus

Honglin Zhu et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2015)

Article Immunology

Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus

Fahimeh Lavi Arab et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2015)

Review Immunology

TGF-beta Activation and Function in Immunity

Mark A. Travis et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Article Immunology

IL-17 Promotes Murine Lupus

Gil Amarilyo et al.

JOURNAL OF IMMUNOLOGY (2014)

Review Rheumatology

Pragmatic approaches to therapy for systemic lupus erythematosus

Wen Xiong et al.

NATURE REVIEWS RHEUMATOLOGY (2014)

Article Pediatrics

Systemic lupus erythematosus and granulomatous lymphadenopathy

Devendra Shrestha et al.

BMC PEDIATRICS (2013)

Review Dermatology

Mesenchymal stem cell therapy in skin: why and what for?

Kiarash Khosrotehrani

EXPERIMENTAL DERMATOLOGY (2013)

Review Cell Biology

Mechanisms of mesenchymal stromal cell immunomodulation

Karen English

IMMUNOLOGY AND CELL BIOLOGY (2013)

Article Rheumatology

Clinical associations of serum interleukin-17 in systemic lupus erythematosus

Fabien B. Vincent et al.

ARTHRITIS RESEARCH & THERAPY (2013)

Review Immunology

Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New

Alessia Alunno et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Review Oncology

Clinical applications of mesenchymal stem cells

Shihua Wang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)

Review Immunology

How mesenchymal stem cells interact with tissue immune responses

Yufang Shi et al.

TRENDS IN IMMUNOLOGY (2012)

Review Immunology

Multipotent mesenchymal stromal cells and the innate immune system

Katarina Le Blanc et al.

NATURE REVIEWS IMMUNOLOGY (2012)

Review Cell & Tissue Engineering

Mesenchymal stem cell effects on T-cell effector pathways

Michelle M. Duffy et al.

STEM CELL RESEARCH & THERAPY (2011)

Review Cell & Tissue Engineering

Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection

Ibrahim Kassis et al.

CURRENT STEM CELL RESEARCH & THERAPY (2011)

Review Biotechnology & Applied Microbiology

IL-17 in Systemic Lupus Erythematosus

Jose C. Crispin et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Article Multidisciplinary Sciences

Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation

Je-Min Choi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Cell & Tissue Engineering

Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells

Kevin Kemp et al.

STEM CELL REVIEWS AND REPORTS (2010)

Article Pathology

Mouse Models of Systemic Lupus Erythematosus Reveal a Complex Pathogenesis

J. B. Rottman et al.

VETERINARY PATHOLOGY (2010)

Article Rheumatology

Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus

Kamini Shah et al.

ARTHRITIS RESEARCH & THERAPY (2010)

Review Dermatology

CD4(+)CD25(+) regulatory T cells in human lupus erythematosus

Annegret Kuhn et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2009)

Article Rheumatology

Th17 and Natural Treg Cell Population Dynamics in Systemic Lupus Erythematosus

Ji Yang et al.

ARTHRITIS AND RHEUMATISM (2009)

Article Immunology

The Role of IL-23/IL-17 Axis in Lupus Nephritis

Zheng Zhang et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Pharmacology & Pharmacy

Anti-Ccl2 Spiegelmer Permits 75% Dose Reduction of Cyclophosphamide to Control Diffuse Proliferative Lupus Nephritis and Pneumonitis in MRL-Fas(lpr) Mice

Onkar Kulkarni et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)

Article Biochemical Research Methods

A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow

Masoud Soleimani et al.

NATURE PROTOCOLS (2009)

Review Immunology

Induction of autoimmunity by pristane and other naturally occurring hydrocarbons

Westley H. Reeves et al.

TRENDS IN IMMUNOLOGY (2009)

Article Rheumatology

Liver Involvement in Systemic Lupus Erythematosus: Case Review of 40 Patients

Vaidehi R. Chowdhary et al.

JOURNAL OF RHEUMATOLOGY (2008)

Review Immunology

FOXP3+ regulatory T cells:: Current controversies and future perspectives

Alison H. Banham et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2006)

Article Immunology

Regulatory T cells in patients with systemic lupus erythematosus

Brenda Alvarado-Sanchez et al.

JOURNAL OF AUTOIMMUNITY (2006)

Article Biochemistry & Molecular Biology

Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice

WN Deng et al.

DNA AND CELL BIOLOGY (2005)

Article Immunology

Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid

CM Reilly et al.

JOURNAL OF IMMUNOLOGY (2004)

Article Biochemistry & Molecular Biology

Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection

M Baddoo et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2003)

Article Cell & Tissue Engineering

Immunomodulatory effects of fetal and adult mesenchymal stem cells

K Le Blanc

CYTOTHERAPY (2003)

Article Biochemistry & Molecular Biology

T cells in the pathogenesis of systemic lupus erythematosus

RW Hoffman

FRONTIERS IN BIOSCIENCE-LANDMARK (2001)

Article Pharmacology & Pharmacy

CTLA4-Ig: a novel immunosuppressive agent

N Najafian et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)